Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01698294 · ClinicalTrials.gov registry record · NA

Biomarkers in Post-Menopausal Women Receiving Flaxseed

A NA study, sponsored by Roswell Park Cancer Institute.

Completed
Registry status
NA
Development phase
258
Enrollment target

NCT01698294: Completed NA study, sponsored by Roswell Park Cancer Institute.

NCT01698294 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 258 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01698294, a NA study, has completed, sponsored by Roswell Park Cancer Institute.

COMPLETED
Registry status
NA
Development phase
258 participants
Enrollment target

Study Summary

This randomized clinical trial studies biomarkers in post-menopausal women receiving flaxseed. Studying samples of blood, urine, and feces in the laboratory from participants receiving flaxseed may help doctors understand the effects of flaxseed on biomarkers.

Interventions

  • OTHER Laboratory Biomarker Analysis
  • OTHER Questionnaire Administration
  • OTHER Clinical Observation
  • DIETARY_SUPPLEMENT Flaxseed

Trial Details

FieldValue
Enrollment Target 258 participants
Start Date 2012-12-14
Est. Completion 2017-06-08
Phase NA
Roswell Park Cancer Institute

365 total trials

What the finished NCT01698294 record still lists

NCT01698294 is an interventional study that assigns participants to a tested intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.

NCT01698294 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01698294 about?

NCT01698294 is a clinical study titled "Biomarkers in Post-Menopausal Women Receiving Flaxseed". This randomized clinical trial studies biomarkers in post-menopausal women receiving flaxseed. Studying samples of blood, urine, and feces in the laboratory from participants receiving flaxseed may help doctors understand the effects of flaxseed on biomarkers.

What is the current status of trial NCT01698294?

This trial is currently completed. It is a NA study. The enrollment target is 258 participants. The study started on 2012-12-14. Estimated completion is 2017-06-08.

What interventions are being tested in trial NCT01698294?

The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER), Clinical Observation (OTHER), Flaxseed (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01698294?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01698294's enrollment target sits among peer trials

258 402nd of 2000 higher than 1,598 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03785288 · 258 participants · Phase 3

    Vaginal Cuff Brachytherapy Fractionation Study

  • NCT04643002 · 258 participants · Phase 1

    Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

  • NCT04924322 · 258 participants · Phase 2

    Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

  • NCT05043012 · 258 participants · NA

    Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01698294, the US trial registry maintained by the National Library of Medicine. NCT01698294 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.